Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 203.62

+1.2%

1:43 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David L. Hachey who wrote (19707)	4/27/1998 11:23:00 PM
From: WTDEC	Read Replies (6) of 32384

Dave, there are many more cases than SEPR. I picked SEPR as I think LGND may very well be in a position similar to where SEPR was a while ago. Check out LGND's STAT platform description in the annual report (also I posted it here on Sunday - sorry forgot the #). It looks like LGND may be able to make many proven drugs which can now only be taken by injection, available in oral form. This reminds me of the SEPR strategy of "taking proven racemic drugs and isolating the active enantiomer and removing a potentially hazardous enantiomer." LGND may make existing drugs a lot easier to take and lower treatment costs quite significantly. In LGND's case, it has a lot more depth because it also has a second platform, Intracellular Receptors, which is starting to bear fruit. I'm glad your long. Regards, Walter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next